US FTC drug middleman report ‘obvious signal’ to pass reform, pharmacists group says
MLex Summary: The National Community Pharmacists Association said the US Federal Trade Commission's second interim staff report on anticompetitive practices by pharmacy benefit managers "is just the latest obvious signal to...To view the full article, register now.
Already a subscriber? Click here to view full article